Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. For as long as I’ve worked in data and analytics, predictions of disappearing roles have ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update from BriaCell Therapeutics ( ...

All eyes will be on the new inflation data coming out tomorrow, but voters have already passed judgement on President Donald Trump’s economic policy, reports CNN data analyst Harry Enten. “My mama was ...

Investing.com - Verastem (NASDAQ:VSTM) shares dropped 13% to $7.90 following GenFleet’s presentation of updated clinical data for GFH375 at the ESMO meeting this past weekend. The decline comes ...

Perspective Therapeutics shares declined after it presented updated interim data from an ongoing Phase 1/2a trial of cancer drug VMT-alpha-NET. The stock was recently down 29% to $3.19 on Monday and ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at ...

https://www.thehindubusinessline.com/markets/global-trends-fpis-move-q2-earnings-to-guide-markets-in-holiday-shortened-week-analysts/article70182129.ece Copy Equity ...

Investing.com -- The Federal Reserve is still likely to cut interest rates next week despite the lack of official data due to the government shutdown, according to Capital Economics’ North America ...

IMNN-001 program is currently advancing its OVATION 3 pivotal Phase 3 trial per plan LAWRENCEVILLE, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc. (Nasdaq: IMNN) , a clinical-stage company in ...

Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Earning a digital marketing degree online can help you expand ...